Compare · GH secretagogue
CJC-1295 vs Ipamorelin
Both are gh secretagogue compounds. Here's how they line up on the evidence — graded the same way.
| CJC-1295 | Ipamorelin | |
|---|---|---|
| Evidence | Preliminary human | Preliminary human |
| Class | GH secretagogue | GH secretagogue |
| Summary | A long-acting GHRH analog that raises GH and IGF-1 in short human trials, but has no clinical-outcome data, is not FDA-approved, and is banned in sport. | A selective growth-hormone-releasing peptide with early human safety data but a failed efficacy trial; never approved and banned in sport. |
| Full profile → | Full profile → |
CJC-1295
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog designed to make the body secrete more of its own growth hormone (GH). Short human studies confirm it raises GH and IGF-1, but no trial has shown it changes any health or performance outcome, and no version is FDA-approved.
Ipamorelin
Ipamorelin is a synthetic peptide that briefly raises growth hormone (GH) levels. It has been tested in humans, but the one trial that measured a real clinical outcome did not work, and it has never been approved for any use.